Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026

Go back to Encouraging Global Phase II Ivonescimab Data in First-Line Metastatic Colorectal Cancer Presented at ASCO 2026
Stratcomm Media, Ltd. (NASDAQ: SMMT) Delayed: 14.28 +0.53 (3.85%)
Previous Close $13.75    52 Week High $19.75 
Open $13.78    52 Week Low $4.26 
Day High $14.40    P/E N/A 
Day Low $13.70    EPS $0.00 
Volume 7,392,225